Starquest Capital Invests $73M In Chinese Drug E-Commerce Firm

Login to View

Chinese pharmaceutical e-commerce company Miaoshou Doctor has secured an RMB500 million (US$72.77 million) series C+ round of financing led by Chinese private equity firm Starquest Capital, with the participation of investors like Sequoia Capital China, Sequoia confirmed to China Money Network on Monday.

Continue reading with a China Money Network subscription

Join Now

Already have an account or paid subscription? Log in